Editorial: Hwang's 'Guardian Angel' Owes Us an Explanation
By Chosun Ilbo,
Chosun Ilbo
| 01. 18. 2006
The presidential advisor for science and technology Park Ky-young received research grants of W150 million (US$150,000) and W100 million in 2001 and 2003 for studies on the ethics and social impact of bio-engineering from the disgraced cloning scientist Hwang Woo-suk. The 2001 research focused on the social impact of creating BSE-resistant cows, and the 2003 work on ethical guidelines and commercial use of bio-organs.
For a start, was the presidential aide, a botanist by training, charged with ethics research because the country is short on specialists in the field? More than 50 are listed as members of the Korean Bioethics Association. To say that her participation in some bioengineering forums as a representative of civic groups qualifies her for the research grants is stretching it.
A botany professor at Sunchon National University, Park joined the camp of President Roh Moo-hyun during the 2002 presidential election. In February 2003, she was a member of Roh's transition team assigned to an economics subcommittee. In June 2003, Park chaired the Future Strategy Subcommittee under the Policy Planning Committee, a presidential advisory body. In...
Related Articles
By Carissa Wong, New Scientist | 07.08.2026
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...